Welcome to the STAGE community!
Congratulations to STAGE trainee Osvaldo Espin-Garcia and STAGE mentor Dr. Lisa Strug who were both invited to give talks at the 2017 International Genetic Epidemiology Society (IGES) Annual Meeting in September in Cambridge, UK. For more details, click here.
STAGE alumni Sarah Gagliano will be moderating a session during the 2017 American Society of Human Genetics (ASHG) Annual Meeting in October in Orlando, Florida, USA. For details on ASHG 2017 sessions, click here
Congratulations to STAGE trainee Saira Mirza!
Saira is the recipient of the Alzheimer Society Research Program (ASRP) Postdoctoral Fellowship which will support her project entitled: Genetic association study of magnetic resonance imaging (MRI) biomarkers of neurodegeneration across dementias – A data-driving approach.
Her application was ranked #1 in her funding stream.
Saira is based at Sunnybrook Health Sciences Centre and was admitted into the STAGE program in September 2016.
The STAGE program is very proud of Saira’s accomplishment !!!
Upcoming Funding Opportunity
2017-2018 Banting Postdoctoral Fellowships Competition
The Banting Postdoctoral Fellowships program is designed to support world-class postdoctoral researchers.
The fellowship provides $70,000 per year for two years.
The program is open to both Canadian and international researchers who have recently completed a PhD, PhD- equivalent, or health professional degree.
Application deadline will be September 20, 2017 at 20:00 EDT.
For complete details: click here
CIHR STAGE is a formal and comprehensive training program in Genetic Epidemiology and Statistical Genetics, the first of its kind in Canada and one of few in the world.
The program offers new training and career development opportunities designed to cross-train individuals at the interface of genetics and population health sciences in genetic epidemiology and statistical genetics—two disciplines currently facing a massive shortage of qualified individuals in Canada and elsewhere. The overall goal is to improve prevention and management of complex diseases by increasing capacity in genetic epidemiology and statistical genetics research.
Participants will receive an enriched training experience, including the following opportunities:
- Stipends at CIHR rates, with option to receive top-up funding.
- Travel and top-up awards for trainees holding or able to obtain other awards or scholarships.
- Co-mentoring by a team of internationally-renowned experts.
- Cross-disciplinary practica in industry, government, or institutional research labs.
- Internships, exchanges, and networking at the local, national, and international levels.
- A curriculum incorporating core, integrative, and cross‑disciplinary courses and leadership training.
The program welcomes:
- Full-time Master’s or Doctoral students enrolled in graduate programs in the Divisions of Biostatistics and Epidemiology at the Dalla Lana School of Public Health, and in the Department of Statistics at the University of Toronto
- Postdoctoral Fellows from relevant disciplines
- Faculty transitioning into the field of genetic epidemiology
- CIHR STAGE will accept applications from exceptional full-time PhD students enrolled in relevant biomedical programs at U of T, with a background in human genetics and evidence of training and strength in quantitative skills.
The expectation is that successful candidates will be nationally competitive for external awards.
“I would like to express my great gratitude to the CIHR STAGE program for the Postdoctoral Training in Genetic Epidemiology and Statistical Genetics. I have achieved tremendous advancement in my career through the rich multi-discipline training environment.” (Aug 2014)
“I am very grateful to CIHR STAGE and the MSFSS for the opportunity to work closely with our international collaborators. My internship in Paris was not only cheese- and croissant-filled, but also a tremendous advancement to my career as a genetic epidemiologist.” (Aug. 2013)
“The mentoring has been fundamental to the progress I have made in moving into a career as a genetic epidemiologist.” (Aug. 2013)
“STAGE has provided me with a unique opportunity to undertake training in Genetic Epidemiology, with a combination of taught courses and hands on research. I have been able to tailor my training to my own personal needs and I have been offered excellent supervision.” (Aug. 2013)
“STAGE has given me the opportunity to gain expertise and experience in methods development with an international researcher. I have been able to join an important research group (INSERM) and get the expertise I was seeking for. Working with a statistician on a regular basis while having more clinical discussion with my Toronto mentor was a unique opportunity.” (Aug. 2013)
“In my search for a training program to meet my specific needs and wishes (i.e. to be able to continue work as a clinician yet also have structured training in genetic epidemiology), I found STAGE to be unique. As far as I am aware there is no other program such as this available anywhere else. It was very fortunate for me that this was on my doorstep!…I would have no reservation to recommend this program to other physicians or trainees in other disciplines. It has been a thoroughly enjoyable, rewarding and positive experience for me. (Jan. 2013)
“I am really enjoying the co-mentoring by my three expert supervisors…I am astonished how the ideas, critique and suggestions from all of them have enriched my project development. I’m also enjoying the list of courses that are offered by the STAGE. I think it is important to fill some gaps/deficiencies from my previous training.” (Dec. 2011)
Sponsors & Partners
CIHR STAGE is funded by the Canadian Institutes of Health Research through the Strategic Training Initiative in Health Research program, and housed at the University of Toronto Dalla Lana School of Public Health (DLSPH).
CIHR STAGE operates in close partnership with the Divisions of Epidemiology and Biostatistics of the DLSPH, the Department of Statistics of the University of Toronto, The Hospital for Sick Children, Princess Margaret Hospital, the Ontario Institute for Cancer Research, and The Samuel Lunenfeld Research Institute of Mount Sinai Hospital.